drugset / Trial / NCT02713139
Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy and safety of the association clotrimazole 200mg and metronidazole 0,75%(Clopistatin 5DT®) and whether it is superior when compared with metronidazole 100mg/g (gynecologic Flagyl®) and clotrimazole 20mg/g (Gino-Canesten® 3) in the syndromic treatment of vaginal discharge from different etiologies.
Timeline
- Start
- 2013-09
- Primary completion
- 2014-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clotrimazole | Unknown | 20 unknown | Other |
| Subject | Clotrimazole | Unknown | 200 mg | Other |
| Subject | Metronidazole | Small molecule | 0.75 % | Other |
| Subject | Metronidazole | Small molecule | 100 unknown | Other |